
Sign up to save your podcasts
Or


As CRC affects younger and more diverse populations, emerging tests for CRC biomarkers provide enormous utility for diagnosis. However, misdiagnosis of CRC, shifting demographics of those afflicted with CRC, and patient unfamiliarity with symptoms create challenges in identifying CRC. In this episode of Inside the Lab, hosts Dr. Ali Brown and Lotte Mulder are joined by Dr. Melissa Taggart, a board-certified pathologist at MD Cancer Center and Karla Valencia, a laboratory manager at MD Anderson Cancer Center to discuss the utility of biomarker testing for CRC.
The hosts are also joined by Sarah Claeys, who was diagnosed with Stage I CRC in 2020 and is now actively fighting Stage IV recurrence with metastatic disease primarily in the liver, and ASCP Patient Champion Heather Tucker, who suffered from misdiagnosis for years before being diagnosed for CRC. She completed treatment 5 years ago. Sarah and Heather share their experiences with seeking both diagnosis and treatment, and provide insights on what information related to biomarkers were most valuable to them.
Topics Covered in this podcast include:
Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter
Connect with Ms. Bartosh, Ms. Courtright & Mr. Bowman
University Health Laboratory Services
Ms. Bartosh on LinkedIn
Connect with Ms. Swails & Dr. Brown
Ms. Swails on Twitter
Dr. Mulder on Twitter
Resources
CAP Inspection Checklists
ASCP Patient Champions Program
Inside the Lab in the ASCP Store
By American Society for Clinical Pathology4.6
4848 ratings
As CRC affects younger and more diverse populations, emerging tests for CRC biomarkers provide enormous utility for diagnosis. However, misdiagnosis of CRC, shifting demographics of those afflicted with CRC, and patient unfamiliarity with symptoms create challenges in identifying CRC. In this episode of Inside the Lab, hosts Dr. Ali Brown and Lotte Mulder are joined by Dr. Melissa Taggart, a board-certified pathologist at MD Cancer Center and Karla Valencia, a laboratory manager at MD Anderson Cancer Center to discuss the utility of biomarker testing for CRC.
The hosts are also joined by Sarah Claeys, who was diagnosed with Stage I CRC in 2020 and is now actively fighting Stage IV recurrence with metastatic disease primarily in the liver, and ASCP Patient Champion Heather Tucker, who suffered from misdiagnosis for years before being diagnosed for CRC. She completed treatment 5 years ago. Sarah and Heather share their experiences with seeking both diagnosis and treatment, and provide insights on what information related to biomarkers were most valuable to them.
Topics Covered in this podcast include:
Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter
Connect with Ms. Bartosh, Ms. Courtright & Mr. Bowman
University Health Laboratory Services
Ms. Bartosh on LinkedIn
Connect with Ms. Swails & Dr. Brown
Ms. Swails on Twitter
Dr. Mulder on Twitter
Resources
CAP Inspection Checklists
ASCP Patient Champions Program
Inside the Lab in the ASCP Store

90,964 Listeners

38,989 Listeners

44,957 Listeners

111,929 Listeners

56,595 Listeners

8,407 Listeners

368,967 Listeners

14,219 Listeners

4,761 Listeners

6,553 Listeners

29,172 Listeners

15,867 Listeners

10,651 Listeners

574 Listeners

10,761 Listeners